The incidence of death due to ILD in anti-MDA5-positive patients was 20.5% (9/44), significantly higher than that of the anti-MDA5-negative group (4.7%, 8/169) (P = 0.002). This evidence concerns the gene IFIH1 and interstitial lung disease.